Ovarian cancer remains the deadliest gynecologic cancer, largely because it is rarely found early. Symptoms are often vague, ...

Multiple myeloma is a cancer in which plasma cells, which normally produce antibodies, multiply uncontrollably in the bone marrow.

March 3 (Reuters) - Diagnostics firm Droplet Biosciences said on Tuesday it is collaborating with Nvidia (NVDA.O), opens new tab to use the chipmaker's AI infrastructure to speed up post-surgery ...

Andres B. Sanchez Alvarado participated in research into combining spectroscopy and ML to analyze complex samples, which has a patent pending. Across the U.S., hundreds of sites on land or in lakes ...

Many eligible patients miss lung cancer screening due to low awareness and systemic barriers, putting underserved groups at higher risk for late-stage disease. She also explained the differences in ...

Imagine detecting cancer with just one drop of blood. This breakthrough test, known as the Anti-Theranos method, makes it possible. “This changes everything,” as early detection becomes faster and ...

A Chicago teenager whose father was detained by U.S. Immigration and Customs Enforcement last year as she was sick with a rare form of cancer has died. Subscribe to read this story ad-free Get ...

When it comes to cancer, waiting for symptoms may soon be old news. Telehealth company Hims & Hers began offering a blood test this week that screens for a wide range of cancers before warning signs ...

According to the American Cancer Society, over two million Americans will be diagnosed with cancer in 2026. Dr. Jen Caudle, a family health physician and associate professor at Rowan University, joins ...

Levy is chief medical officer at Visana Health. Konety is president of Allina Health Cancer Institute and chief medical officer at Astrin Biosciences. On Jan. 20, the House of Representatives passed a ...

Detecting cancer in the earliest stages could dramatically reduce cancer deaths because cancers are usually easier to treat when caught early. To help achieve that goal, MIT and Microsoft researchers ...